دورية أكاديمية
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
| العنوان: | MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial |
|---|---|
| المؤلفون: | Raab, Marc S., Engelhardt, Monika, Blank, Antje, Goldschmidt, Hartmut, Agis, Hermine, Blau, Igor W., Einsele, Hermann, Ferstl, Barbara, Schub, Natalie, Röllig, Christoph, Weisel, Katja, Winderlich, Mark, Griese, Janine, Härtle, Stefan, Weirather, Johannes, Jarutat, Tiantom, Peschel, Christian, Chatterjee, Manik |
| المصدر: | The Lancet. Haematology. - 7, 5 (2020) , e381-e394, ISSN: 2352-3026 |
| سنة النشر: | 2020 |
| المجموعة: | University of Freiburg: FreiDok |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://freidok.uni-freiburg.de/data/167079Test |
| DOI: | 10.1016/S2352-3026(19)30249-2 |
| الإتاحة: | https://doi.org/10.1016/S2352-3026Test(19)30249-2 https://freidok.uni-freiburg.de/data/167079Test |
| رقم الانضمام: | edsbas.4D41C733 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/S2352-3026(19)30249-2 |
|---|